Theravance Biopharma, Inc. (TBPH)
Sep 23, 2026 - TBPH was delisted (reason: acquired by ZYME)
17.03
0.00 (0.00%)
Inactive · Last trade price on Sep 23, 2026
Theravance Biopharma Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Theravance Biopharma stock had an average target of $17.67, with a low estimate of $17 and a high estimate of $19.
Price Target: $17.67 (+3.76%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Aug 11, 2026.
Analyst Ratings
The average analyst rating for Theravance Biopharma stock from 4 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 3 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Maintains $17 | Hold | Maintains | $17 | -0.18% | Aug 11, 2026 |
| BTIG | BTIG | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 29, 2026 |
| JonesTrading | JonesTrading | Hold Downgrades $19 → $17 | Hold | Downgrades | $19 → $17 | -0.18% | Jun 29, 2026 |
| TD Cowen | TD Cowen | Hold Reiterates $15 | Hold | Reiterates | $15 | -11.92% | May 8, 2026 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | -0.18% | Apr 7, 2026 |
Financial Forecast
Revenue This Year
90.68M
from 107.46M
Decreased by -15.62%
Revenue Next Year
100.10M
from 90.68M
Increased by 10.39%
EPS This Year
0.21
from -0.15
EPS Next Year
1.28
from 0.21
Increased by 507.14%
EPS and Forward PE are based on non-GAAP adjusted numbers.